Trials / Sponsors / Alfred Chung, MD
Alfred Chung, MD
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 1 | 2025-07-28 |
| Withdrawn | Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (AL AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease | Phase 1 / Phase 2 | 2024-01-08 |
| Terminated | Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 2 | 2022-05-03 |